Sabinsa launches curcumin analog ingredient called CurCousin

The new branded ingredient contains Calebin A, a curcumin analog, and supports balanced cholesterol, healthy blood sugar levels, circulation, as well as weight management.

Sabinsa Corp. (East Windsor, NJ) has developed a new product sourced from turmeric called CurCousin. The new branded ingredient contains Calebin A, a curcumin analog naturally present in Curcuma longa and Curcuma caesia, and supports balanced cholesterol, healthy blood sugar levels, circulation, as well as weight management through the inhibition of adipogenesis (formation of fat cells).

A study published in International Journal of Ayurveda and Pharma Research1 found that 25 mg of Calebin A taken twice daily for 90 days, significantly reduced body weight and body mass index in overweight and obese subjects, compared to placebo. They also saw significant reductions in serum biomarkers like leptin, adiponectin and cortisol, as well as improved blood lipid profiles. Sabinsa holds 65 U.S. and international patents on CurCousin, and the ingredient is also self-affirmed GRAS (generally recognized as safe).

“Deep knowledge of curcumin has been a passion of our research teams for many years, and has resulted in industry leading ingredients like Curcumin C3 Complex,” said Muhammed Majeed, PhD, chairman and founder of Sabinsa, in a press release. “We’re enthusiastic about the potential of CurCousin and eager to share details about it with our customers across the world.”

Reference

  1. Majeed M et al. “Efficacy and tolerability of a novel formulation for weight management in obese subjects: a randomized, double-blind, placebo-controlled, clinical trial.” International Journal of Ayurveda and Pharma Research, vol. 4, no. 11 (2016):10-17